The high mutation rate of SARS-CoV-2 genomic RNA has made COVID-19 more difficult to eradicate using currently available interventions. Hence. newer pharmaceutical strategies must be developed. especially those generally complementary and alternative medicines. https://www.ngetikin.com/quick-offer-1-Gallon-Universal-Primer-Pro-Deep-Penetrating-Primer-big-deal/